Searchable abstracts of presentations at key conferences in endocrinology

ea0022p359 | Diabetes | ECE2010

Waiting time for emergency renal replacement therapy in patients with end stage renal failure secondary to diabetes mellitus

Rodriguez Florisa , Triana Javier , Tamez Hector Eloy , Robles Sofia Daniela

Introduction: The incidence of end stage renal failure (ESRF) secondary to diabetes mellitus (DM) is increasing worldwide. Renal replacement therapy, which if started early improves prognosis, is a common treatment for ESRF.Objective: To determine the waiting time and factors that influence the provision of emergency renal replacement therapy in patients with ESRF secondary to DM admitted to the emergency room of a tertiary care hospital.<p class="ab...

ea0022p507 | Growth factors | ECE2010

GH modulates migration of developing T cells

Dardenne Mireille , Smaniotto Salete , Da Cruz Daniela Mendes , Savino Wilson

In the context of the cross-talk between the neuroendocrine and immune systems, it is well known that GH exerts physiological effects in central as well as peripheral compartments of the immune system. GH modulates a variety of thymic functions. For example, GH upregulates proliferation of thymocytes and thymic epithelial cells. Accordingly, GH-transgenic mice, as well as animals and humans treated with exogenous GH, exhibit an enhanced cellularity in the organ. GH also stimul...

ea0022p590 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Sleeping apnea syndrome (SAS) in acromegaly and obesity

Amzar Daniela , Mihaicuta Stefan , Golu Ioana , Balas Melania , Zosin Ioana

The aim of the study: Acromegaly is associated with respiratory and cardiovascular morbidities and high mortality rate. The present study evaluates clinical aspects in acromegalic and obese patients with sleep apnea syndrome (SAS).Material and method: The patients were diagnosed and followed-up in the Clinic of Endocrinology, Timisoara, in the period 2006–2009. All the cases were confirmed and investigated as present guidelines recommend. The polyso...

ea0022p840 | Thyroid | ECE2010

Isolated maternal hypothyroxinemia in women with gestational diabetes mellitus and its connection to necessity of insulinotherapy

Krcma Michal , Dvorakova Eva , Cechurova Daniela , Vokurkova Lenka , Rusavy Zdenek

Introduction: Isolated maternal hypothyroxinemia leads to higher prevalence of children autism, attention-deficit/hyperactivity disorder and mild cognitive deficiency. Frequency of hypothyroxinemia among women with gestational diabetes mellitus (GDM) is unclear and routine screening is not well established.Objective: Find prevalence of maternal isolated hypothyroxinemia in women with GDM and assess relations with necessity of insulinotherapy.<p class...

ea0016p15 | Adrenal | ECE2008

The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas: hormonal and mutation screening

Lazurova Ivica , Wagnerova Hedwiga , Habalova Viera , Dudasova Daniela

The aim of the present study was to evaluate and compare the response of 17 OHP to ACTH stimulation in patients with various types of adrenal incidentalomas and to examine the occurence of germline CYP21 mutation in these patients.Subjects and methods: Forty patients (27 females, 13 males) with unilateral and bilateral masses were screened for five most common mutations of the CYP21 in peripheral blood DNA samples. A hormonal evaluation, i.e. baseline pl...

ea0016p163 | Clinical cases | ECE2008

Clinical presentation of a patient with pseudohypoparathyroidism type 1a (Albright syndrome)

Madaras Gabriela , Fulop Erika , Popoviciu Daniela , Balazs Jozsef , Madaras Zoltan

Background: Pseudohypoparathyroidism (PHP) is a heterogeneous group of disorders characterized by hypocalcemia, hyperphosphatemia, increased serum concentration of parathyroid hormone (PTH) and insensitivity to the biological activity of PTH.Case report: We present the case of a 38-year-old man admitted to the Neurology Clinic in November 2007 for a witnessed grand mal seizure that resolved without intervention. Patient had a history of mental retardatio...

ea0016p545 | Obesity | ECE2008

The volume of left hepatic lobe as metabolic marker, correlates with weight and not with height, both in obese or non-obese women and men

Peretianu Dan , Carsote Mara , Staicu Daniela Cristea , Poiana Catalina

Introduction: Left hepatic lobe volume (LHLV) has been associated with hyperinsulinemia and insulin resistance in obese women.Aim: To study the correlation between LHLV and body weight, regardless the weight and gender of the patient.Subjects and methods: The left hepatic lobe was evaluated with an echographic probe of 3.5 MHz. The LHLV (cm3) was calculated with the formula: antero-posterior diameter (length)×longit...

ea0016p751 | Thyroid | ECE2008

Same aspects regarding immunohistochemical diagnosis of papillary thyroid carcinoma

Zosin Ioana , Golu Ioana , Cornianu Marioara , Amzar Daniela , Balas Melania

The study evaluates the expression of same immunohistochemical (IHC) markers (Ki-67, PCNA, CK-19, HBME-1 and Galectin 3, in the diagnosis of differentiated thyroid carcinomas.Material and methods: The study group comprised 57 patients with thyroid tumors; aged 17–71 years (mean age 48.96 years). All cases were evaluated before surgical treatment by means of clinical examination, thyroid ultrasonography and fine needle aspiration biopsy (FNAB).<p...

ea0014p150 | (1) | ECE2007

Adrenal incidentalomas and insulin sensitivity – are there any differences between adenomas and hyperplasia?

Dudasova Daniela , Lazurova Ivica , Wagnerova Hedviga , Dravecka Ingrid

It is well known that adrenal masses, particularly adenomas are frequently related to metabolic syndrome and insulin resistance. However, there are no reported data about the differences between adenomas and hyperplasia.Authors examined the prevalence of symptoms of the metabolic syndrome and insulin resistance in 25 patients with adrenal incidentalomas (10 men, 15 women) of the mean age 57.9+15 years. 15 patients had adrenal adenoma determined by CT or ...

ea0014p166 | (1) | ECE2007

Cabergoline suppression test in distinguishing the variability of response to dopamine agonists in prolactinomas

BADIU Corin , VOICU Daniela , Caragheorgheopol Andra , Hortopan Dan , Silvestro Luigi

Primary therapy in prolactinomas, the most frequent pituitary adenomas, consists in ergot derivatives dopamine agonists (bromocriptine or cabergoline) which lowers prolactin levels and shrink the tumour. Bromocriptine was the first drug used, but the therapeutic levels are attained after several days/weeks, therefore an acute suppression test is not possible. However, the biological response is variable and 10% of prolactinomas are resistant to medical therapy. In order to eva...